(Q45165295)

English

HER-2/neu as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel.

scientific article published in August 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15567936%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

HER-2/neu as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15567936%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15567936%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15567936%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Gunter von Minckwitz

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15567936%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

S Chan

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15567936%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

M Paesmans

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15567936%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

K Friedrichs

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15567936%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

T Pinter

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15567936%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

V Cocquyt

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15567936%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

E Murray

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15567936%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

I Bodrogi

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15567936%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

B Lesperance

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15567936%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

S Korec

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15567936%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

J Crown

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15567936%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

P Simmonds

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15567936%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

J Y Leroy

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15567936%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

V Durbecq

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15567936%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

J Isola

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15567936%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

M Aapro

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15567936%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

M J Piccart

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15567936%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

D Larsimont

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15567936%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

language of work or name

0 references

publication date

1 August 2004

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15567936%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15567936%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

86

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15567936%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

197-206

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15567936%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15567936%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

https://scigraph.springernature.com/pub.10.1023/b:brea.0000036783.88387.47

0 references

Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000036783.88387.47

21 January 2018

Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000036783.88387.47

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000036783.88387.47

7 January 2021

based on heuristic

inferred from DOI database lookup

erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000036783.88387.47

7 January 2021

based on heuristic

inferred from DOI database lookup

erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000036783.88387.47

7 January 2021

based on heuristic

inferred from DOI database lookup

HER2 and choice of adjuvant chemotherapy for invasive breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-15

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000036783.88387.47

7 January 2021

based on heuristic

inferred from DOI database lookup

HER-2 and topo-isomerase IIalpha as predictive markers in a population of node-positive breast cancer patients randomly treated with adjuvant CMF or epirubicin plus cyclophosphamide

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000036783.88387.47

7 January 2021

based on heuristic

inferred from DOI database lookup

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000036783.88387.47

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000036783.88387.47

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000036783.88387.47

7 January 2021

based on heuristic

inferred from DOI database lookup

p53 status and the efficacy of cancer therapy in vivo

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000036783.88387.47

7 January 2021

based on heuristic

inferred from DOI database lookup

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000036783.88387.47

7 January 2021

based on heuristic

inferred from DOI database lookup

p53-independent apoptosis induced by paclitaxel through an indirect mechanism

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000036783.88387.47

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45165295&oldid=2126628902"